NewsRoom Articles - Page 122 of 154 - PsychedelicNewsWire (PNW)

WednesdaySep 02, 2020 3:52 pm

Study Shows That Psychedelic Drugs Decrease Depressive Symptoms

The latest research gives preliminary confirmation that psychedelic drugs can better an individual’s mental health by making them more accepting of experiences that are distressing. Frontiers in Psychiatry published the study, adding to an already expanding body of literature which shows that utilizing substances such as psilocybin can improve symptoms of depression. Therapy using psychedelics has shown a lot of potential for treating various mental health disorders, such as major depressive disorder, substance use disorders and distress related to a life-threatening ailment. As compared to pharmacological use of drugs to treat different mental health issues, psychedelic therapy results last anywhere…

TuesdaySep 01, 2020 12:15 pm

Daily Practice, Community and Psychedelic Integration

Integration is a very significant aspect of inner work, especially with regard to psychedelics. It involves an individual figuring out the many rewards of self that come with deep inner work, how to balance it out in the real world and receiving support as one comprehends these new revelations. Mostly, intense inner work is usually carried out in sessions or workshops. However, the process carries over even after the session is completed. This is the crucial part as it involves a lot of intense material or emotions and an individual is supposed to allow themselves the time to work through…

MondayAug 31, 2020 12:29 pm

Cybin Corp. at Forefront of Change in Psilocybin-Based Treatments

Company focused on furthering R&D of psilocybin-based medications Cybin believes psychedelic substances derived from mushrooms can work as boosters for brain Psilocybin shows promise for an array of mental health issues Cybin Corp. is a leading life-science company focused on psychedelic and nutraceutical products to support various psychiatric and neurological conditions. The company is engaged in clinical trials, through a partnership with the Toronto Centre for Psychedelic Science (“TCPS”) to gain regulatory approval for psilocybin and other psychedelic products (http://ibn.fm/RgpQc). In the 1940s, the study of psychedelic drugs for the treatment of mental health conditions began with the discovery of LSD.…

MondayAug 31, 2020 11:05 am

Pure Extract Technologies Inc. Ideally Positioned to Become Leader in White Label Market

Company’s Standard Processing License pending approval from Health Canada After licensing approval, Pure Extracts will be launching white label production as part of core services Pure Extracts facility designed to produce high-quality, high-purity formulations on a commercial scale Pure Extract Technologies, a Canadian plant-based extraction company operating in the functional medicinal mushrooms space, is preparing to become a leading contender in the white labeling space. The Company’s Standard Processing License is currently pending approval from Health Canada; upon approval the Company will be launching white label production as part of its core services. As an expert in the extraction field,…

MondayAug 31, 2020 10:00 am

Psychedelics, Ego Death and the Brain

Contemporary neuroscience has shown that psychedelics like psilocybin, LSD and ayahuasca significantly decrease activity in the brain’s DMN (default mode network). This decline in DMN action in a way reboots one’s brain and is associated with one of the lasting therapeutic effects of psychedelic substances. The DMN is an interlinked group of brain regions that are linked to introspective functions and internally directed thoughts like self-criticism and self-reflection. The practical connections that constitute the DMN grow between birth and adulthood. It is not until the age of five that a child develops ‘ego’ or a stable sense of narrative self.…

FridayAug 28, 2020 12:15 pm

Congressman Helps Raise Money to Legalize Psilocybin Mushroom Therapy

The representative for Oregon's 3rd Congressional district Earl Francis Blumenauer, who is a chief advocate for cannabis reform, formally announced his support of Oregon’s initiative to legalize psilocybin mushrooms to be used for therapeutic purposes. He is also helping to raise money for the company. He stated in a mass email that he fully supported the measure as it addresses mental health which is key issue in the community, in a responsible and innovative way. Additionally, he stated that the legalization of psilocybin therapy was an important tool that deserved everyone’s support. The measure in question, Measure 109, provides residents…

ThursdayAug 27, 2020 2:45 pm

Mental Health: The Second Pandemic. Is Psychedelic-Assisted Therapy the Answer?

Largely due to the COVID-19 pandemic and the lockdowns imposed in various jurisdictions around the world, mental health issues have become the new topic of discussion. According to the Journal of the American Psychiatric Nurses Association, the psychological torrent from COVID-19 is likely to develop into a completely distinct pandemic of its own. Other organizations such as the United Nations and World Health Organization have also cited the possible mental health emergency as something that should not be ignored. A study carried out by JAPNA highlights the need for new and better mental health interpositions as a way to prepare…

WednesdayAug 26, 2020 10:00 am

The Multidisciplinary Association for Psychedelic Studies Raises $30M to Complete MDMA Study

On Thursday, the Multidisciplinary Association for Psychedelic Studies (“MAPS”) reported it had collected $30 million in donations, which will be used in the completion of a study on the use of MDMA to help remedy PTSD, or post-traumatic stress disorder. MAPS stated that the funds would be used in the MDMA trials, which is a Phase 3 study, in a bid to secure approval from the FDA. The FDA had before identified MDMA, commonly referred to as ecstasy, as “breakthrough therapy” using earlier trials as their basis. In total, an estimated 2,500 individuals donated to help MAPS get to their…

TuesdayAug 25, 2020 11:16 am

Psychedelics Decriminalization Petition Awaits Response from the Canadian Government

A petition that called for the decriminalization of psychedelics garnered about 15,000 signatures surpassing the required 500 signatures and will be read formally in the House of Commons after sessions resume on September 23. It talks about the different uses of entheogen plants and fungi as well as the substances’ therapeutic potential. After it’s been introduced, the government has 45 days to put out a response. The MP Paul Manly of the Green Party who sponsored the petition revealed bigger plans for the bill, saying that he’d continue his support while pushing for decriminalization of possession of all drugs that…

MondayAug 24, 2020 10:00 am

Oakland Activists Unveil Guidelines for Planned Psychedelic Healing Ceremonies Upon Prospective Legalization

Lawmakers in Oakland have achieved a major milestone in the use of psychedelics when they spearheaded a successful drive to decriminalize plant and fungi-based psychedelics. The move allows members of the public to consume ayahuasca and psilocybin mushrooms without fear of landing in jail. In their next push to legalize psychedelic healing ceremonies, the psychedelics activists have rolled out a myriad of safety guidelines that participants in entheogenic healing ceremonies will follow once legalization occurs. The healing ceremonies involve the use of entheogenic substances believed to have healing capabilities. So far, the practice awaits legislation to have legal backing. Decriminalize…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000